Chandigarh University’s Biotechnology and Pharmaceutical Sciences programmes have achieved remarkable success in placements, with students securing job offers from leading companies like IDS Infotech, Cryoviva Biotech Pvt. Ltd., and Serum Institute of India.
Sun Pharmaceutical Industries has secured a crucial approval from ANVISA to manufacture and market Semaglutide injection in Brazil for the treatment of adults with inadequately controlled type 2 diabetes mellitus. This approval marks Sun Pharma’s second international approval for Semaglutide, reflecting the strength of the company’s development and manufacturing capabilities.
Dabur India shares fall 2% on Thursday, despite reporting solid Q1 numbers. Analysts maintain ratings but trim target prices due to concerns over revenue momentum and elevated input costs.
KPIT Technologies reports a 32% decline in net profit to Rs 117 crore in Q1 FY27, amidst concerns over the impact of AI on the country’s software services sector. Revenue growth and earnings decline, what’s next for KPIT Tech?
ChrysCapital has acquired a controlling 70.68% stake in Novartis India Limited (NIL) for ₹1,446 crore, marking its first majority-controlled investment in the Indian pharmaceutical sector. The acquisition brings a longstanding pharmaceutical business under dedicated private equity ownership, with the ambition to build a leading branded-generics platform for the Indian market.
The Indian stock market witnessed a broad-based rally on Wednesday, driven by a shift in investor sentiment towards the Indian IT sector. The rally was fueled by a decline in crude oil prices, strong stock-specific action, and the release of positive Q1 results. As the market continues to move higher, investors should keep a close eye on the Nifty’s support level and the performance of the Indian IT sector.
Karnataka Bank reports a significant improvement in its financial performance for the first quarter of the year, with a 43% jump in profit. The bank’s asset quality has improved, leading to a reduction in provision requirements, and its operating profit and net interest income have also shown a notable increase.
Dhanlaxmi Bank has reported a significant improvement in its Q1 results, with its profit more than doubling to ₹24.91 crore. The bank’s interest income has also seen a substantial increase, while bad loans have declined. This positive trend is expected to boost investor confidence in the bank.
Indian benchmark indices Sensex and Nifty staged a significant rebound, closing over 1 per cent higher, propelled by robust performances from IT stocks, HDFC Bank, and a resurgence in foreign fund inflows. As the market continues to navigate through a landscape of mixed global market signals, investors are advised to stay vigilant and keep a close eye on market trends.
Thangamayil Jewellery reports an 86% year-over-year increase in net profit to Rs 85 crore for the first quarter of FY27, with a 71.2% jump in revenue from operations. However, the company’s weak guidance for the second quarter has led to a 10% decline in its stock price.
